Patent system damaging research

October 28, 2003

The UK patent system is damaging scientific research and creating a old rush mentality according to the Royal Society.The current …

Outlook improving for GSK

October 28, 2003

Human genome sequence completed

October 28, 2003

The project to decode the human genome has been completed two years ahead of schedule, but scientists have warned against …

GSK claims victory in US parallel import row

October 27, 2003

GlaxoSmithKline has claimed victory in its controversial bid to block parallel imports of its drugs from Canada into the US.The …

Swiss franc undercuts Roche growth

October 27, 2003

Sales revenues at Roche have been dealt a serious blow by currency fluctuations in the first quarter, with a strong …

Patent system damaging research

October 27, 2003

The UK patent system is damaging scientific research and creating a "gold rush mentality", according to the Royal Society.The current …

Human genome sequence completed

October 27, 2003

The project to decode the human genome has been completed two years ahead of schedule, but scientists have warned against …

Humira launch costs hit Abbott

October 27, 2003

Abbott Labs recorded a 6% drop in profits for the first quarter of 2003 following heavy spending on the launch …

New CHAI head quits

October 27, 2003

Set back for GSK in Augmentin court battle

October 27, 2003

GlaxoSmithKline has suffered a set back in its bid to see off early US generic competition for antibiotic Augmentin, one …

MEPs vote to ban embryonic stem cell research

October 27, 2003

European MPs have voted to ban the use of human cloning and embryonic stem cells for research purposes.The vote could …

Evans says no to OGS

October 27, 2003

Bipolar disorder included in NICE work programme

October 27, 2003

NHS professionals are to be given new clinical guidelines in two important areas of mental health as part of NICE's …

‘Bogus disease’ argument flares up again

October 27, 2003

The British Medical Journal has accused the pharmaceutical industry of creating bogus disease areas in order to sell treatments.The respected …

Exanta promise for AstraZeneca

October 27, 2003

AstraZeneca's new anticoagulant Exanta has shown to be more effective than warfarin in preventing stroke in patients suffering from arrhythmia.Exanta …

The Gateway to Local Adoption Series

Latest content